Elbit Systems earnings ahead as backlog conversion comes into focus By Investing.com

Analysts expect Elbit (ESLT) to report Q4 EPS of $2.70 on revenue of $2.09B for the quarter ended Dec. 31 (EPS +1.5% YoY; revenue +8.29% YoY; revenue +8.9% sequential, EPS -3.6% sequential). Key items: a $25.2B order backlog plus >$1B in new contracts (largest individual wins $435M, $228M, $120.5M) and a premium valuation (market cap $40.6B, trailing P/E ~89x) while the stock is up 146% over the past year trading at $871.11. Investors will focus on backlog conversion timing, margin trajectory (gross margin ~24%, operating income growth +50% TTM) and full-year 2026 guidance to justify the elevated multiple; the print is likely to move the stock by a few percent depending on execution commentary.

Analysis

Elbit’s near-term story will hinge less on headline order intake and more on execution cadence: when multi-year awards move from contract signing to recognized revenue and where margin dilution occurs in the conversion chain. Expect the critical bottlenecks to be subcontractor capacity for high-precision electronics and long-lead semiconductors, plus integration labor ramp—these create lumpy revenue recognition and can depress margins even as bookings grow.

A premium market multiple already prices in sustained margin expansion and seamless program execution; the shortest route to a re-rating higher is clear, repeatable evidence of faster throughput (quarter-over-quarter ramp in shipped systems, not just signed contracts) and demonstrable unit-cost reductions. Conversely, sequential margin weakness will be punished disproportionately because the upside is conditional on defense budgets continuing to flow and the company proving scale efficiency across multiple platforms.

Second-order winners include niche suppliers with excess capacity in sensors, power management, and active-protection subsystems—these firms can capture outsized share if Elbit accelerates production; losers will be less-flexible integrators whose balance sheets can't pre-fund supplier buildouts. Key near-term catalysts to watch are program milestone billings, working-capital swings tied to advance payments, and any government-level acceptance tests that accelerate final deliveries; each can move EBITDA conversion by several percentage points within a single quarter.

Key Decisions for Investors

• Event-driven long ESLT equity sized to 2-3% of sector exposure on a pullback following the print: enter within the first two trading days if management gives explicit quarter-over-quarter conversion metrics and definitive guidance on margin trajectory. Target 25-40% upside over 6-12 months if execution commentary is positive; stop-loss at 12-15% below entry to limit blow-up risk from a missed recognition quarter.
• Directional hedge: pair trade long ESLT / short a large-cap U.S. defense prime (e.g., LMT or RTX) in equal notional terms for a 6–12 month horizon to isolate company-specific execution risk from broad defense-spend beta. Expect asymmetric payoff if Elbit proves conversion speed—aim for 30-50% relative outperformance; cap drawdown by rebalancing monthly and trimming the short if macro risk-off increases.
• Options tactical: buy a 6–9 month call spread on ESLT (buy nearer-ATM call, sell 25–35% OTM call) to cap premium outlay while retaining upside from a positive execution print. Risk limited to premium paid; target 2.5x-4x return if markets re-rate on improved margin guidance or accelerated shipments.
• Credit/FX watch: monitor supplier financing and NWC disclosures over the next two quarters—if working capital turns markedly negative (improved cash conversion), consider increasing equity exposure; if capex and receivables spike, rotate to select small-cap subsystem suppliers with clean balance sheets to capture second-order gains.